EVH EBITDA Growth
Evolent Health Inc Class A · EBITDA Growth
EVH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-3204.12%period ending
EVH TTM EBITDA YoY % (-83.33% → -3204.12%)
Year-over-year change
High-resolution chart · PNG
EVH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -3,204.1198% | |
| -1,070.9463% | |
| -549.8799% | |
| -69.6104% | |
| -84.6887% | |
| -28.0843% | |
| 521.4316% | |
| 432.4904% | |
| 350.3716% | |
| 259.6229% | |
| -162.4018% | |
| -62.4215% | |
| -145.8495% | |
| -145.3373% | |
| -49.9648% | |
| -33.7956% | |
| 154.1549% | |
| 136.3704% | |
| 125.9751% | |
| 110.3148% | |
| 105.2669% | |
| 35.8365% | |
| 6.5689% | |
| -783.0831% | |
| -894.3463% | |
| -752.4247% | |
| -5,961.3921% | |
| -375.2521% | |
| -181.9013% | |
| -9.7381% | |
| 89.7228% | |
| 82.8084% | |
| 76.9163% | |
| 54.9477% | |
| 81.6768% | |
| 69.7158% | |
| 67.0599% | |
| 69.0076% | |
| -515.4845% | |
| -744.0694% | |
| -1,467.576% | |
| -7,970.5218% | |
| -164.2594% | |
| -83.327% |